Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites. - Wikidata - wikimedia - TriplyDB

Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites.

Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites.

http://www.wikidata.org/entity/Q33768911

about

A review of malaria vaccine clinical projects based on the WHO rainbow table Profiling the host response to malaria vaccination and malaria challenge Complex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell Antigens IMPIPS: the immune protection-inducing protein structure concept in the search for steric-electron and topochemical principles for complete fully-protective chemically synthesised vaccine development Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens.Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein.Genetic immunisation by liver stage antigen 3 protects chimpanzees against malaria despite low immune responses.Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites.Infection with Plasmodium berghei boosts antibody responses primed by a DNA vaccine encoding gametocyte antigen Pbs48/45.Plasmodium falciparum liver stage antigen-1 is cross-linked by tissue transglutaminase.A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.Combining liver- and blood-stage malaria viral-vectored vaccines: investigating mechanisms of CD8+ T cell interference.Analyzing cellular immunity to AAV in a canine model using ELISPOT assay Effects of type I interferons on the adjuvant properties of plasmid granulocyte-macrophage colony-stimulating factor in vivo.Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization.Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria.Pre-erythrocytic malaria vaccines: towards greater efficacy.GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine.Pre-erythrocytic malaria vaccines: identifying the targets.Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells.IgA response and protection following nasal vaccination of chickens with Newcastle disease virus DNA vaccine nanoencapsulated with Ag@SiO2 hollow nanoparticles.Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines.Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki.Current progress of DNA vaccine studies in humans.Induction of an Antibody Response against Plasmodium falciparum F2RIIEBA by Heterologous Prime-boost Immunisation.World Malaria Day 2009: what malaria knows about the immune system that immunologists still do not.Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma.Establishing acceptance criteria for cell-mediated-immunity assays using frozen peripheral blood mononuclear cells stored under optimal and suboptimal conditions.Controlled Human Malaria Infection: Applications, Advances and Challenges.Malaria DNA vaccine gp96NTD-CSP elicits both CSP-specific antibody and CD8(+) T cell response.

P2860

Q21034112-75894359-54B6-4BAB-9F70-0FF517663843 Q26800494-885891C5-8B2D-4585-921E-CE9C262F2BA4 Q28551311-F54D201B-64A3-47FE-AA91-B3E47EDA9514 Q30373743-4853D4F2-FC81-4F5F-AB96-1244BF2A16A0 Q33303670-B911F0EB-C2B7-4DFB-A358-67DC7B2484E7 Q33318466-7893DBDB-ABE9-4380-AC63-747AAF728A81 Q33351936-ECA5EE0D-9B1C-431C-AF0C-59DC51C3E8A7 Q34128586-AAC2CD26-EAA8-4740-B0AD-4D3E786755C5 Q34298647-913ED5FB-8EA6-4703-B1F3-051F0AEF5BE5 Q34492582-F6E8155A-F87D-41F2-824E-A40DE1F99203 Q34567297-41F57B47-5413-4F66-BA06-89F6A59BC341 Q34571072-1CFBA51F-00D9-47EB-8041-24618EE553C4 Q35073970-861C1131-8073-4FA7-A7E8-F4E6FFBEDA0C Q35771456-8F584863-0756-46D6-B415-4403B3A48DCA Q35892390-391F4F46-CAAD-4A2C-B814-AA9DB95C8720 Q36099003-1DFFCCA2-247D-45B3-A1EA-6F9AF05420DA Q36285998-B9F51AE4-7714-4B92-8B38-FDFC1426F679 Q36353548-1A2DF270-3437-4361-888E-A6A158F186BC Q36383811-2854F2FF-0C2F-420F-99C1-F184174A5C7C Q36403400-EAC2344F-073A-42D1-8143-6ECB7E2672BE Q36407775-6CEFCAAF-6CEB-4D54-B0CA-280E2E7E2493 Q36644236-150B6241-D5A3-4ADF-B5EB-A68A0DAD5284 Q36694820-4B78FCD8-4351-49F8-A8C5-2F64D9B2F4DF Q36780146-9D71807E-7421-401B-9E2C-FBC97B283564 Q36893661-4EE284F0-9E80-4F82-9EC6-361B69E502E6 Q36930811-AE5A094B-6762-49B1-9F32-35E4A85E96F7 Q37052790-35508D5D-754F-48A2-8245-3B52DF23DADB Q37103923-D197655D-2935-479F-AB56-EF0A60C9F661 Q37236697-7B230FA1-BBAC-4A40-ABA3-E6D7DA1416FB Q37426820-F841AC5A-A946-48E4-BCC1-861B491E191D Q37540578-171394E8-2C22-4A4B-B182-03F4E676E1F1 Q42800541-51DE219C-CAA4-4EF7-8CDA-D057C9D085EA Q44168331-BCD84A9B-81FA-4584-AD32-01E162B53C88 Q47906081-664BE909-0564-48D6-922A-165D1DC5942F

P2860

Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites.

http://www.wikidata.org/entity/Q33768911

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Boosting of DNA vaccine-elicit ...... exposure to malaria parasites.

@ast

Boosting of DNA vaccine-elicit ...... exposure to malaria parasites.

@en

type

label

Boosting of DNA vaccine-elicit ...... exposure to malaria parasites.

@ast

Boosting of DNA vaccine-elicit ...... exposure to malaria parasites.

@en

prefLabel

Boosting of DNA vaccine-elicit ...... exposure to malaria parasites.

@ast

Boosting of DNA vaccine-elicit ...... exposure to malaria parasites.

@en

P1433

Q33768911-2B7FC259-C072-4BE5-A4E5-89E6676C1C3D

P1476

Q33768911-4B49FD81-FF0C-4893-ACC5-A103C73A0E50

P2093

Q33768911-16A3F601-6427-4F30-88DA-DDC3A6206AD7

Q33768911-57EA68F5-A80B-4770-B0D0-FBE99EFD3570

Q33768911-62F4FB19-19DE-41D7-A2F4-D7C4233EB928

Q33768911-66BEDD50-2055-418D-B036-FA7DAA1FD9F2

Q33768911-6CA5F6FB-17D3-439E-B378-62D785D7F188

Q33768911-8CEF187E-0D16-4E63-A2C0-A0F25E2CFDCE

Q33768911-90B502DE-03C4-4D28-BDA4-2AB56663F605

Q33768911-9C660B0C-1254-4898-815A-9A321B9817DD

Q33768911-AF95BFBF-C160-4CFA-961E-CDE6B911E414

Q33768911-DEFDFBDF-D68F-42CE-805C-1DD380EEDF3F

P2860

Q33768911-009D811E-6454-4720-8605-F66DA3871910

Q33768911-071C2785-B611-4EBD-AEEE-FE124C9CCEB5

Q33768911-0B9C92CC-88C4-4904-8B45-D95FBEF97F73

Q33768911-2020F2DD-C8D0-4870-80F5-9192D8235753

Q33768911-28708D2F-60CC-40C9-B095-4F548DAAC70D

Q33768911-3D09B0FE-4BC2-47C4-8769-1DAA7DF497B6

Q33768911-3D522EA7-8A35-4CAB-B0E4-5B9C1FA3C85B

Q33768911-4F0B053A-C7E0-4DD3-9BDA-3F0C05895EF1

Q33768911-50FFBF2F-B7C0-428B-BFFF-22070BBDCA30

Q33768911-6811EE8B-0C22-42A8-A528-CA7AAD63EFAE

P304

Q33768911-3FB134BD-F414-4B57-A6E5-93F5767BAF5F

P31

Q33768911-08084535-DF46-4665-8F25-BC2C120D0E48

P356

Q33768911-CA256185-4671-4286-AE1E-DDA58F2A8E02

P407

Q33768911-D33AC59B-4EB7-46D2-A88A-D761E570EFB4

P433

Q33768911-11B4A8CC-D815-489B-83AD-6262B312896F

P478

Q33768911-47B59D42-4DE4-49CE-9AAC-5FC453703BEF

P50

Q33768911-28B23DCB-20BD-4A9B-9D0F-A94397AE674A

Q33768911-7D4805C6-9A55-478D-885B-0421C064EEE0

P577

Q33768911-2D4C77D4-7FF3-4179-BD2D-CE907BF909E4

P698

Q33768911-7A9AE3F2-9075-43F5-B6D8-3175A7730CC1

P921

Q33768911-0D807F41-EB19-4365-BB21-68D9F256BAEB

P932

Q33768911-E65DE050-F1D7-4DFD-87CF-03245353234B

P356

IAI.73.5.2863-2872.2005

P1433

Infection and Immunity

P1476

Boosting of DNA vaccine-elicit ...... exposure to malaria parasites.

@en

P2093

Daniel A Freilich

http://www.w3.org/2001/XMLSchema#string

Jo-Glenna Banania

http://www.w3.org/2001/XMLSchema#string

Jon Norman

http://www.w3.org/2001/XMLSchema#string

Judith E Epstein

http://www.w3.org/2001/XMLSchema#string

Maria Fe Baraceros

http://www.w3.org/2001/XMLSchema#string

Nancy Rahardjo

http://www.w3.org/2001/XMLSchema#string

Ruobing Wang

http://www.w3.org/2001/XMLSchema#string

Tanya Gay

http://www.w3.org/2001/XMLSchema#string

Thomas Luke

http://www.w3.org/2001/XMLSchema#string

Yupin Charoenvit

http://www.w3.org/2001/XMLSchema#string

P2860

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein

Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites

Applications of, and future challenges for, genetic vaccines.

HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles.

Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids

Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA

Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3

DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation.

P304

2863-2872

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.73.5.2863-2872.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

Thomas L. Richie

Stephen L Hoffman

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15845492

http://www.w3.org/2001/XMLSchema#string

P921

P932

1087336

http://www.w3.org/2001/XMLSchema#string